endoxan 1 g inj. sol. (lyoph.) i.v. vial
baxter sa-nv - cyclophosphamide monohydrate 1070 mg - eq. cyclophosphamide 1000 mg - lyophilisate for solution for injection - 1 g - cyclophosphamide 1000 mg - cyclophosphamide
uromitexan 400 mg
megapharm ltd - mesna - solution for injection - mesna 400 mg/vial - mesna - prevention of urinary passage toxicity of oxazaphosphorines (ifosfamide ,cyclophosphamide, trofosamide), in particular in high-risk patients with previous radiation therapy in the area of the lesser pelvis, cystitis with previous ifosfamide, cyclophosphamide or trofosamide , urinary passage diseases in anamnesis.
endoxana
baxter healthcare limited - cyclophosphamide monohydrate - coated tablets - 50 milligram - cyclophosphamide
endoxana coated tablets 50 mg
baxter holding b.v. - cyclophosphamide monohydrate - coated tablet - 50 milligram(s) - nitrogen mustard analogues; cyclophosphamide
endoxana 50mg coated tablets
baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - cyclophosphamide - coated tablet - cyclophosphamide 50 mg - antineoplastic agents
endoxan-asta
baxter healthcare ltd - cyclophosphamide monohydrate 100mg - powder for injection - 100 mg - active: cyclophosphamide monohydrate 100mg excipient: mannitol
endoxan-asta
baxter healthcare ltd - cyclophosphamide monohydrate 213.8mg equivalent to 200 mg cyclophosphamide anhydrous. - powder for injection - 200 mg - active: cyclophosphamide monohydrate 213.8mg equivalent to 200 mg cyclophosphamide anhydrous.
endoxan 500mg powder for injection iv
baxter healthcare phils inc - cyclophosphamide monohydrate - powder for injection iv - 500mg
endoxan 1g powder for injection iv
baxter healthcare phils inc - cyclophosphamide monohydrate - powder for injection iv - 1g
blenoxane
bristol-myers squibb (nz) limited - bleomycin sulfate 15000 [iu] equivalent to to 10 mg. - powder for injection - 15000 iu - active: bleomycin sulfate 15000 [iu] equivalent to to 10 mg.